These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19426174)

  • 1. Heterogeneity of systemic inflammatory responses to periodontal therapy.
    Behle JH; Sedaghatfar MH; Demmer RT; Wolf DL; Celenti R; Kebschull M; Belusko PB; Herrera-Abreu M; Lalla E; Papapanou PN
    J Clin Periodontol; 2009 Apr; 36(4):287-94. PubMed ID: 19426174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periodontal infection profiles in type 1 diabetes.
    Lalla E; Kaplan S; Chang SM; Roth GA; Celenti R; Hinckley K; Greenberg E; Papapanou PN
    J Clin Periodontol; 2006 Dec; 33(12):855-62. PubMed ID: 17092237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of periodontal therapy on the regulation of soluble cell adhesion molecule expression in aggressive periodontitis patients.
    Pischon N; Hägewald S; Kunze M; Heng N; Christan C; Kleber BM; Müller C; Bernimoulin JP
    J Periodontol; 2007 Apr; 78(4):683-90. PubMed ID: 17397316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating interleukin-6 and high-sensitivity C-reactive protein decrease after periodontal therapy in otherwise healthy subjects.
    Marcaccini AM; Meschiari CA; Sorgi CA; Saraiva MC; de Souza AM; Faccioli LH; Tanus-Santos JE; Novaes AB; Gerlach RF
    J Periodontol; 2009 Apr; 80(4):594-602. PubMed ID: 19335079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum inflammatory mediators in pregnancy: changes after periodontal treatment and association with pregnancy outcomes.
    Michalowicz BS; Novak MJ; Hodges JS; DiAngelis A; Buchanan W; Papapanou PN; Mitchell DA; Ferguson JE; Lupo V; Bofill J; Matseoane S; Steffen M; Ebersole JL
    J Periodontol; 2009 Nov; 80(11):1731-41. PubMed ID: 19905943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between arsenic exposure from drinking water and plasma levels of cardiovascular markers.
    Wu F; Jasmine F; Kibriya MG; Liu M; Wójcik O; Parvez F; Rahaman R; Roy S; Paul-Brutus R; Segers S; Slavkovich V; Islam T; Levy D; Mey JL; van Geen A; Graziano JH; Ahsan H; Chen Y
    Am J Epidemiol; 2012 Jun; 175(12):1252-61. PubMed ID: 22534204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress and inflammatory markers in relation to circulating levels of adiponectin.
    Gustafsson S; Lind L; Söderberg S; Zilmer M; Hulthe J; Ingelsson E
    Obesity (Silver Spring); 2013 Jul; 21(7):1467-73. PubMed ID: 23585283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-cardiolipin and increased serum adhesion molecule levels in patients with aggressive periodontitis.
    Schenkein HA; Best AM; Brooks CN; Burmeister JA; Arrowood JA; Kontos MC; Tew JG
    J Periodontol; 2007 Mar; 78(3):459-66. PubMed ID: 17335369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: association with malnutrition, inflammation, and cardiovascular disease.
    Stenvinkel P; Lindholm B; Heimbürger M; Heimbürger O
    Nephrol Dial Transplant; 2000 Oct; 15(10):1624-30. PubMed ID: 11007832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of treatment of chronic periodontitis on levels of serum markers of acute-phase inflammatory and vascular responses.
    Ide M; McPartlin D; Coward PY; Crook M; Lumb P; Wilson RF
    J Clin Periodontol; 2003 Apr; 30(4):334-40. PubMed ID: 12694432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating adhesion molecules, matrix metalloproteinase-9, plasminogen activator inhibitor-1, and myeloperoxidase in coronary artery disease patients with stable and unstable angina.
    Tretjakovs P; Jurka A; Bormane I; Mikelsone I; Elksne K; Krievina G; Reihmane D; Verbovenko J; Bahs G
    Clin Chim Acta; 2012 Jan; 413(1-2):25-9. PubMed ID: 22024218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periodontal treatment decreases levels of antibodies to Porphyromonas gingivalis and citrulline in patients with rheumatoid arthritis and periodontitis.
    Okada M; Kobayashi T; Ito S; Yokoyama T; Abe A; Murasawa A; Yoshie H
    J Periodontol; 2013 Dec; 84(12):e74-84. PubMed ID: 23701010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of etanercept on serum levels of soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor in patients with rheumatoid arthritis.
    Klimiuk PA; Sierakowski S; Domyslawska I; Chwiecko J
    Scand J Rheumatol; 2009; 38(6):439-44. PubMed ID: 19922018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of periodontal treatment on serum leptin, interleukin-6, and C-reactive protein.
    Shimada Y; Komatsu Y; Ikezawa-Suzuki I; Tai H; Sugita N; Yoshie H
    J Periodontol; 2010 Aug; 81(8):1118-23. PubMed ID: 20370420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periodontitis-associated up-regulation of systemic inflammatory mediator level may increase the risk of coronary heart disease.
    Nakajima T; Honda T; Domon H; Okui T; Kajita K; Ito H; Takahashi N; Maekawa T; Tabeta K; Yamazaki K
    J Periodontal Res; 2010 Feb; 45(1):116-22. PubMed ID: 19602107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assessment of serum levels of adhesion molecules (sICAM-1, sVCAM-1, sE-selectin) in stable and unstable angina and acute myocardial infarction].
    Bossowska A; Kiersnowska-Rogowska B; Bossowski A; Galar B; Sowiński P
    Przegl Lek; 2003; 60(7):445-50. PubMed ID: 14750416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble cell adhesion molecules and parameters of lipoprotein metabolism in patients with severe burns.
    Rassoul F; Richter V; Kistner C; Wisser D; Reichert B
    West Indian Med J; 2009 Nov; 58(5):417-21. PubMed ID: 20441058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of carbohydrate versus fat restriction on serum levels of adipocytokines, markers of inflammation, and endothelial function among women with the metabolic syndrome: a randomized cross-over clinical trial.
    Rajaie S; Azadbakht L; Saneei P; Khazaei M; Esmaillzadeh A
    Ann Nutr Metab; 2013; 63(1-2):159-67. PubMed ID: 24021709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of periodontal therapy on systemic markers of inflammation in patients with metabolic syndrome: a controlled clinical trial.
    López NJ; Quintero A; Casanova PA; Ibieta CI; Baelum V; López R
    J Periodontol; 2012 Mar; 83(3):267-78. PubMed ID: 21749167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.
    Wållberg-Jonsson S; Cvetkovic JT; Sundqvist KG; Lefvert AK; Rantapää-Dahlqvist S
    J Rheumatol; 2002 May; 29(5):875-82. PubMed ID: 12022343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.